Year-Long test for new COPD inhaler begins
NCT ID NCT07425210
Summary
This study aims to check the long-term safety and effectiveness of an experimental inhaler called HSK39004 for people with moderate-to-severe COPD. About 300 adults aged 40-80 will use the inhaler twice daily for a full year. The main goal is to monitor for any side effects while seeing if the treatment helps control breathing problems over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guizhou Provincial People's Hospital
Guiyang, Guizhou, 550002, China
Conditions
Explore the condition pages connected to this study.